Mission Therapeutics

Mission Therapeutics is a private, drug discovery and development company focused on selectively targeting deubiquitylating enzymes to treat diseases of high unmet need. Mission has built a world-leading platform for the discovery and development of first-in-class, small-molecule drugs that selectively target deubiquitylating enzymes (DUBs) an emerging, and hitherto intractable, drug class that is attracting significant commercial interest as the potential Next Kinase Area. Missions DUB platform is yielding a rich pipeline of novel therapeutics for the benefit of patients across therapeutic areas. Missions strategy is to create value by advancing its pipeline programmes through early clinical development, and preferentially with...

Drug discovery,oncology,neurodegeneration,ubiquitin,deubiquitylating enzymes,and cancer

Mission therapeutics operates in the Biotechnology research industry.

Mission therapeutics's revenue is 11m - 100m

Mission therapeutics has 11 - 50 employees.